◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › AVR

Anteris Technologies Global Corp. (AVR) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Instruments & Supplies · DATA UPDATED 2026-07-15

Anteris Technologies Global Corp. (AVR) operates in the Medical Instruments & Supplies industry and is headquartered in Toowong, Australia with about 174 employees. Its market capitalization is roughly $871 million.

Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Interactive charts & full statements → Open the AVR valuation workbench →

AVR Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$3M$3M$6M
Gross Profit$1M$0M$2M
Operating Income (EBIT)($47M)($32M)($16M)
Net Income($46M)($31M)($17M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

AVR Free Cash Flow History

AVR Balance Sheet History

Balance sheet2023-12-312022-12-312021-12-31
Total Assets$30M$16M$21M
Total Liabilities$12M$7M$11M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AVR viewer.

Other Companies in Medical Instruments & Supplies

← AVPTAll stocksAVT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.